Dr. Jason Crowell talks with Dr. Elsmarieke van de Giessen and Emma Coomans about a newly FDA-approved tau-binding radiotracer [18F]flortaucipir and an accompanying visual read method to support the diagnostic process in cognitively impaired patients assessed for Alzheimer disease.

Read the related article in Neurology.

Disclosures can be found at Neurology.org.

свернуть